We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email ：PharmaSources@imsinoexpo.com
Whatsapp ：+86-13621645194
Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Eastern Europe,Australasia,Asia,Middle East,Africa
Sample Provided: no
Features:
1. High temperature resistance, can be repeatedly sterilized at 121'C conditions;
2. Equipped with anti-fogging agent, anti-fog function is good;
3. Wide vision, can be worn at the same time with myopia glasses;
4. The tightening belt can be adjusted according to the head circumference.
Scope of application: The product can effectively meet the requirements of dust, fog or other chemical liquid spatter protection, especially with excellent high temperature resistance, can meet the requirements of medicine, food and other high-temperature sterilization industry applications.
Product qualification: In June 2020, the medical isolation eye mask obtained the CE certificate issued by the global authoritative certification and testing organization TUV Rheinland, Germany, and has been qualified for overseas export. At the same time, it has a domestic class of medical device filing certificate and production filing certificate.
Note:
1. Please read the product instructions carefully or purchase and use under the guidance of medical personnel;
2. Please refer to the instruction manual for taboos or precautions;
3. Advertisement approval number: Hushi Guangxiang (document) No. 240531-31352
Two years of qualification
Audited Supplier
Pharma Sources Insight JANUARY 2024
